caspofungin acetate + Comparator: Micafungin sodium
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Fungal Infection
Conditions
Fungal Infection
Trial Timeline
Aug 1, 2008 → Jul 1, 2010
NCT ID
NCT00717860About caspofungin acetate + Comparator: Micafungin sodium
caspofungin acetate + Comparator: Micafungin sodium is a phase 3 stage product being developed by Merck for Fungal Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT00717860. Target conditions include Fungal Infection.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00717860 | Phase 3 | Completed |
Competing Products
20 competing products in Fungal Infection